top of page
Gut Inflammation (60 Capsules) (Stable BPC-157, KPV, PEA, Tributyrin)

Gut Inflammation (60 Capsules) (Stable BPC-157, KPV, PEA, Tributyrin)

$315.00Price

Buy-Gut Inflammation (60 Capsules) (Stable BPC-157, KPV, PEA, Tributyrin) online usa

 

Gut inflammation research capsules contain 250mcg Stable BPC-157 Arginate Form, 500mcg Larazotide, 500mcg KPV. This research product has the ability to treat numerous gut problems such as gluten intolerance, inflammatory bowel disease, and auto-immune diseases such as Type 1 diabetes and Hashimoto’s thyroiditis.

Reducing Lung Failure and Right Ventricle Enlargement of Heart.

"In this study, when administered intraperitoneally from Days 1-29, BPC 157 inhibited the development of muscularization and hypertrophy of the media in pulmonary arteries, it prevented pulmonary hypertension and the right heart hypertrophy and failure... Moreover, the death rate significantly decreased in those animals treated with BPC 157."  "Isoprenaline myocardial infarction suitably mimicks human myocardial ischemia. As an anti-ulcer peptide that also improves wound healing (including transected muscle), BPC 157 was shown as safe in trials for inflammatory bowel disease (PL14736, Pliva). This peptide also showed positive effect in heart failure model induced by doxorubicine and heart arryhthmias induced by hypoxic and reoxygenation injury."

"This study has demonstrated protective effect of pentadecapeptide BPC 157 on mycardial infarction induced by isoprenaline in rats and its potentional clinical application in treatment of ishemic heart disease. The results of this study are in accord with previously demonstrated protective effect on endothelial cells and induction of NO by this peptide in various organ's leasons."

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

bottom of page
<